SCHEMBL4396304

SCHEMBL4396304

NC1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(Cl)cc4)n3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 10/20 0.53
PIK3CA P42336 2/20 0.53
PIK3CB P42338 2/20 0.53
PIK3CG P48736 2/20 0.53
JAK2 O60674 2/20 0.52
CHUK O15111 8/20 0.51
IKBKG Q9Y6K9 6/20 0.50
MAPK8 P45983 1/20 0.50
MAPK10 P53779 1/20 0.50
MEN1 O00255 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
KMT2A Q03164 1/20 0.50
PRKCZ Q05513 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MTOR P42345 1/20 0.49
SMG1 Q96Q15 1/20 0.49
CAMK2D Q13557 3/20 0.49
HDAC3 O15379 1/20 0.48
NCOR1 O75376 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4066207 0.99 IKBKB (0.53) IKBKBPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL8254568 0.91 JAK2 (0.55) IKBKBPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL11924743 0.90 GRM5 (0.60) IKBKBPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL8312581 0.89 CDK1 (0.58) IKBKBPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL14021219 0.89 PIK3CA (0.58) IKBKBPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL5070960 0.88 IKBKB (0.64) IKBKBPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL11924733 0.88 MTOR (0.60) IKBKBPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL14021190 0.88 MTOR (0.60) IKBKBPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL8247959 0.87 IKBKB (0.63) IKBKBPIK3CAPIK3CGJAK2CHUK
SCHEMBL8312662 0.87 KMT2A (0.53) IKBKBPIK3CAPIK3CBPIK3CGJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1349841-B1 ANILINOPYRIMIDINE DERIVATIVES AS IKK INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO SIGNAL PHARM LLC (US) 2009-12-02 EP disclosed
EP-1349841-B1 ANILINOPYRIMIDINE DERIVATIVES AS IKK INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO SIGNAL PHARM LLC (US) 2009-12-02 EP disclosed
EP-1349840-B1 ANILINOPYRIMIDINE DERIVATIVES AS JNK PATHWAY INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO SIGNAL PHARM LLC (US) 2009-03-11 EP disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed
EP-1349841-A2 ANILINOPYRIMIDINE DERIVATIVES AS IKK INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO SIGNAL PHARMACEUTICALS, INC. (US) 2003-10-08 EP disclosed
WO-2002046171-A2 ANILINOPYRIMIDINE DERIVATIVES AS IKK INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO SIGNAL PHARMACEUTICALS, INC. (US) 2002-06-13 WO disclosed